Understanding inflammatory bowel disease via immunogenetics.
暂无分享,去创建一个
[1] Judy H. Cho,et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.
[2] Vinod Chandran,et al. Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci , 2015, Nature Communications.
[3] Maria Fichera,et al. Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. , 2015, The New England journal of medicine.
[4] Samuel I. Miller,et al. Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohn's Disease , 2015, Inflammatory bowel diseases.
[5] Manolis Kellis,et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers , 2015, Nature Genetics.
[6] Hailiang Huang,et al. High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis , 2014, Nature Genetics.
[7] M. Daly,et al. Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.
[8] M. Neurath,et al. Mongersen , an Oral SMAD 7 Antisense Oligonucleotide , and Crohn ’ s Disease , 2015 .
[9] Aaron J. Sams,et al. Accounting for eXentricities: Analysis of the X Chromosome in GWAS Reveals X-Linked Genes Implicated in Autoimmune Diseases , 2014, bioRxiv.
[10] E. Eskin,et al. Integrating Functional Data to Prioritize Causal Variants in Statistical Fine-Mapping Studies , 2014, PLoS genetics.
[11] P. Visscher,et al. Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data. , 2014, Human molecular genetics.
[12] J. Petrosino,et al. The dynamics of a family’s gut microbiota reveal variations on a theme , 2014, Microbiome.
[13] Carl A. Anderson,et al. Genetic studies of Crohn's disease: Past, present and future , 2014, Best practice & research. Clinical gastroenterology.
[14] J. Ott,et al. Genome-wide association scan in north Indians reveals three novel HLA-independent risk loci for ulcerative colitis , 2014, Gut.
[15] A. Kostic,et al. The microbiome in inflammatory bowel disease: current status and the future ahead. , 2014, Gastroenterology.
[16] P. Rosenstiel,et al. XIAP variants in male Crohn's disease , 2014, Gut.
[17] M. Daly,et al. Searching for missing heritability: Designing rare variant association studies , 2014, Proceedings of the National Academy of Sciences.
[18] Jun S. Liu,et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery , 2013 .
[19] D. Philpott,et al. NOD proteins: regulators of inflammation in health and disease , 2013, Nature Reviews Immunology.
[20] H. Uhlig. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease , 2013, Gut.
[21] M. Pirinen,et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.
[22] Judy H. Cho,et al. Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis , 2013, PLoS genetics.
[23] Miles Parkes,et al. Genetic insights into common pathways and complex relationships among immune-mediated diseases , 2013, Nature Reviews Genetics.
[24] Yusun Jung,et al. Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations , 2013, Gut.
[25] Suzanne M. Leal,et al. Identifying Rare Variants Associated with Complex Traits via Sequencing , 2013, Current protocols in human genetics.
[26] B. B. Finlay,et al. The role of the immune system in governing host-microbe interactions in the intestine , 2013, Nature Immunology.
[27] Peter Donnelly,et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci , 2013, Nature Genetics.
[28] Todd A. Johnson,et al. A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population. , 2013, Gastroenterology.
[29] H. Shin,et al. Genome-Wide Association Study of Ulcerative Colitis in Koreans Suggests Extensive Overlapping of Genetic Susceptibility With Caucasians , 2013, Inflammatory bowel diseases.
[30] A. M’Koma,et al. Inflammatory Bowel Disease: An Expanding Global Health Problem , 2013, Clinical medicine insights. Gastroenterology.
[31] J. González,et al. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project , 2012, Gut.
[32] David C. Wilson,et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.
[33] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[34] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[35] Subrata Ghosh,et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.
[36] Sarah Edkins,et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease , 2011, Nature Genetics.
[37] Wei-Li Di,et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. , 2011, The New England journal of medicine.
[38] Joshua M. Korn,et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease , 2011, Nature Genetics.
[39] R. Xavier,et al. Genetics and pathogenesis of inflammatory bowel disease , 2011, Nature.
[40] G. Abecasis,et al. Low-coverage sequencing: implications for design of complex trait association studies. , 2011, Genome research.
[41] A. Di Stefani,et al. Efalizumab , 2011, Expert opinion on drug safety.
[42] Tariq Ahmad,et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 , 2011, Nature Genetics.
[43] Cisca Wijmenga,et al. A Meta-Analysis of Genome-Wide Association Scans Identifies IL18RAP, PTPN2, TAGAP, and PUS10 As Shared Risk Loci for Crohn's Disease and Celiac Disease , 2011, PLoS genetics.
[44] S. Brant. Update on the heritability of inflammatory bowel disease: the importance of twin studies. , 2011, Inflammatory bowel diseases.
[45] D. Seo,et al. Efalizumab, a Human Monoclonal Anti-CD11a Antibody, in the Treatment of Moderate to Severe Crohn’s Disease: An Open-Label Pilot Study , 2011, Digestive Diseases and Sciences.
[46] Tariq Ahmad,et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.
[47] B. Psaty,et al. Genetic predictors of medically refractory ulcerative colitis , 2010, Inflammatory bowel diseases.
[48] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[49] Malfertheiner,et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. , 2010, Inflammatory bowel diseases.
[50] Yusuke Nakamura,et al. A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population , 2009, Nature Genetics.
[51] R. D. Hatton,et al. Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective , 2009, Nature Reviews Immunology.
[52] A. Schäffer,et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.
[53] P. Donnelly,et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region , 2010 .
[54] S. Targan,et al. Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells , 2009, European journal of immunology.
[55] Ying Wang,et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus , 2009, Nature Genetics.
[56] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[57] J. Satsangi,et al. The genetics of Crohn's disease. , 2009, Annual review of genomics and human genetics.
[58] Emily H Turner,et al. Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.
[59] Judy H. Cho,et al. Erratum: Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study(Nature Genetics (2009) 41 (216220)) , 2009 .
[60] Hilary G. Morrison,et al. Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation , 2009, Infection and Immunity.
[61] B. Sands,et al. Epidemiology of inflammatory bowel disease and overview of pathogenesis. , 2009, Medicine and health, Rhode Island.
[62] Kathryn Roeder,et al. Ulcerative colitis loci on chromosomes 1 p 36 and 12 q 15 identified by genome-wide association study , 2009 .
[63] A. Zhernakova,et al. Detecting shared pathogenesis from the shared genetics of immune-related diseases , 2009, Nature Reviews Genetics.
[64] B. Maher. Personal genomes: The case of the missing heritability , 2008, Nature.
[65] D. Strachan,et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility , 2008, Nature Genetics.
[66] Les Dethlefsen,et al. The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing , 2008, PLoS biology.
[67] Judy H. Cho,et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.
[68] Alastair Forbes,et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease , 2008, Nature Genetics.
[69] B. Maher,et al. The case of the missing heritability , 2008 .
[70] Simon C. Potter,et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A , 2007, Nature.
[71] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[72] W. Sandborn,et al. Inflammatory bowel disease: clinical aspects and established and evolving therapies , 2007, The Lancet.
[73] Judy H Cho,et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.
[74] Simon Heath,et al. Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4 , 2007, PLoS genetics.
[75] Thomas Lengauer,et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 , 2007, Nature Genetics.
[76] Judy H. Cho,et al. A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.
[77] U. Turunen,et al. Family and twin studies in inflammatory bowel disease. , 2006, World journal of gastroenterology.
[78] Lon R Cardon,et al. Evaluating coverage of genome-wide association studies , 2006, Nature Genetics.
[79] J. Ragoussis,et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. , 2005, Human molecular genetics.
[80] M. Olivier. A haplotype map of the human genome , 2003, Nature.
[81] J. Ragoussis,et al. Single nucleotide polymorphisms in TNFSF 15 confer susceptibility to Crohn ’ s disease , 2005 .
[82] Yusuke Nakamura,et al. Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease , 2004, Journal of Human Genetics.
[83] E. Loftus. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. , 2004, Gastroenterology.
[84] P. Donnelly,et al. The Fine-Scale Structure of Recombination Rate Variation in the Human Genome , 2004, Science.
[85] Yusuke Nakamura,et al. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease , 2003, Journal of Human Genetics.
[86] John P A Ioannidis,et al. Genetic associations: false or true? , 2003, Trends in molecular medicine.
[87] L. Cardon,et al. Analysis of the IBD5 locus and potential gene-gene interactions in Crohn’s disease , 2003, Gut.
[88] Lucia Mirea,et al. A Population- and Family-Based Study of Canadian Families Reveals Association of HLA DRB1*0103 With Colonic Involvement in Inflammatory Bowel Disease , 2003, Inflammatory bowel diseases.
[89] L. Cardon,et al. Analysis of the IBD 5 locus and potential gene-gene interactions in Crohn ’ s disease , 2003 .
[90] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[91] Judy H. Cho,et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.
[92] J. Cavanaugh,et al. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. , 2001, American journal of human genetics.
[93] M. Daly,et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.
[94] J. Cavanaugh. The international IBD genetics consortium confirms linkage of Crohn's disease to a locus on chromosome 16 (IBD1) , 2000 .
[95] L. Cardon,et al. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. , 1998, Gastroenterology.
[96] E. Jabs,et al. American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. , 1998, Gastroenterology.
[97] S. Foote,et al. Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16 , 1998, Annals of human genetics.
[98] M. Parkes,et al. Susceptibility loci in inflammatory bowel disease , 1996, The Lancet.
[99] S. Targan,et al. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. , 1996, Human molecular genetics.
[100] N Risch,et al. The Future of Genetic Studies of Complex Human Diseases , 1996, Science.
[101] D. Jewell,et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease , 1996, The Lancet.
[102] Jean Weissenbach,et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16 , 1996, Nature.
[103] M. Pericak-Vance,et al. Confirmation of genetic heterogeneity in limb-girdle muscular dystrophy: linkage of an autosomal dominant form to chromosome 5q. , 1992, American journal of human genetics.
[104] J. Weber,et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease , 1992, Nature genetics.
[105] J. Haines,et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. , 1991, The New England journal of medicine.
[106] M. Pericak-Vance,et al. Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17 , 1989, Experimental Neurology.
[107] M. Pericak-Vance,et al. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene , 1987, Cell.
[108] L. Tsui,et al. Cystic Fibrosis Locus Defined by a Genetically Linked Polymorphic Dna Marker Author(s): Lap , 2022 .
[109] A. Young,et al. A polymorphic DNA marker genetically linked to Huntington's disease , 1983, Nature.
[110] W. Silen,et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. , 1958, Surgery.